(HealthDay)—Early therapeutic anticoagulation does not appear to affect survival among critically ill adults with COVID-19, according to a study published online Jan. 26 in the Annals of Internal Medicine.
Jan 28, 2021
0
3
For patients with non-small cell lung cancers (NSCLC) marked by RET gene fusions, the targeted therapy selpercatinib was well tolerated and achieved durable objective responses, or tumor shrinkage, in the majority of participants ...
Aug 27, 2020
0
47
In a Phase II trial led by researchers at The University of Texas MD Anderson Cancer Center, the combination of dabrafenib, a BRAF inhibitor, and trametinib, a MEK inhibitor, achieved a 51% overall response rate (ORR) in ...
Aug 18, 2020
0
1
(HealthDay)—As of July 29, there have been a total of 570 U.S. cases of multisystem inflammatory syndrome in children (MIS-C), according to research published in the Aug. 7 early-release issue of the U.S. Centers for Disease ...
Aug 13, 2020
0
3
A study of electronic medical records from US Veterans Health Administration medical centers has found that hydroxychloroquine—with or without azithromycin—did not reduce the risk of ventilation or death and was associated ...
Jun 5, 2020
0
14
(HealthDay)—Persons aged 60 to 69 years with COVID-19 are the most commonly hospitalized, according to a research letter published online April 24 in the Journal of the American Medical Association.
Apr 28, 2020
0
1
(HealthDay)—For patients with COVID-19 who have ST-segment elevation, indicating potential acute myocardial infarction, there is considerable variability in presentation, and prognosis is poor, according to a letter to ...
Apr 22, 2020
0
1
(HealthDay)—Greater alcohol consumption is associated with lower serum levels of bone formation markers among patients living with HIV and substance use disorder, according to a study published online March 2 in Alcoholism: ...
Apr 3, 2020
0
2
(HealthDay)—Listen up, guys: A healthy diet is good for your brain and heart, and also your sperm, new research suggests.
Feb 21, 2020
0
63
(HealthDay)—For patients with chronic lymphocytic leukemia (CLL) in routine care, overall survival improved from 1995 to 2017, according to a study recently published in Leukemia & Lymphoma.
Dec 26, 2019
0
6
